Compounds > 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone
Page last updated: 2024-11-03

4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone and Dermatitis, Atopic

4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone has been researched along with Dermatitis, Atopic in 4 studies

4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone: Inhibitor of phosphodiesterases.

Dermatitis, Atopic: A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema.

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19903 (75.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chan, SC4
Li, SH1
Hanifin, JM4
Butler, JM1
Ebertz, M1
Stevens, SR1
Sobieszczuk, D1
Cooper, KD2
Kang, K1

Other Studies

4 other studies available for 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone and Dermatitis, Atopic

ArticleYear
Increased interleukin-4 production by atopic mononuclear leukocytes correlates with increased cyclic adenosine monophosphate-phosphodiesterase activity and is reversible by phosphodiesterase inhibition.
    The Journal of investigative dermatology, 1993, Volume: 100, Issue:5

    Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Adult; Cyclic AMP; Dermatitis, Atopic; Humans; Inter

1993
Basophil histamine release in atopic dermatitis and its relationship to disordered cyclic nucleotide metabolism.
    Acta dermato-venereologica. Supplementum, 1985, Volume: 114

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Basophils; Carb

1985
Lymphocyte and monocyte localization of altered adrenergic receptors, cAMP responses, and cAMP phosphodiesterase in atopic dermatitis. A possible mechanism for abnormal radiosensitive helper T cells in atopic dermatitis.
    Acta dermato-venereologica. Supplementum, 1985, Volume: 114

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; B-Lymphocytes;

1985
Phosphodiesterase inhibition by Ro 20-1724 reduces hyper-IgE synthesis by atopic dermatitis cells in vitro.
    The Journal of investigative dermatology, 1985, Volume: 84, Issue:6

    Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Adolescent; Adult; Cell Separation; Depression, Chem

1985